# Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication

> **NCT06340724** · PHASE3 · COMPLETED · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 104 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Vonoprazan
- **DRUG:** Amoxicillin
- **DRUG:** Banxiaxiexin decoction

## Key facts

- **NCT ID:** NCT06340724
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-15
- **Primary completion:** 2024-11-30
- **Final completion:** 2025-01-15
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06340724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06340724, "Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06340724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*